NCT00151138View on ClinicalTrials.gov

Cognitive/Cerebrovascular Consequences of HTN Treatment

NACompletedINTERVENTIONAL
Enrollment

50

Participants

Timeline

Start Date

September 30, 2002

Study Completion Date

May 31, 2007

Conditions
Hypertension
Interventions
DRUG

Atenolol (drug), Lisinopril (drug)

Trial Locations (1)

15213

Dept of Psychiatry, University of Pittsburgh, Pittsburgh

All Listed Sponsors
collaborator

National Heart, Lung, and Blood Institute (NHLBI)

NIH

lead

University of Pittsburgh

OTHER

NCT00151138 - Cognitive/Cerebrovascular Consequences of HTN Treatment | Biotech Hunter | Biotech Hunter